查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1557252

全球婴儿奶粉市场 - 2024 年至 2029 年预测

Global Infant Formula Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

婴儿奶粉市场预计到 2029 年将达到 842.68 亿美元，预测期内复合年增长率为 5.60%，较 2024 年的 641.83 亿美元增长。

婴儿奶粉，或称为婴儿配方奶粉，是专门为一岁以下婴儿提供营养和维生素的配方奶粉。这些配方奶粉可以帮助婴儿缓解胃食道逆流，也可以帮助新生儿增加体重。它还可以给予早产儿和低出生体重儿，为他们提供发育所需的基本补充品、矿物质和热量。

根据评估，增加女性就业和增加女性在全球劳动力中的参与度将推动婴儿奶粉市场的发展。预计女性加入劳动市场将增加可支配收入，并进一步减少全球市场参与企业的母乳哺育。根据世界银行的讯息，过去两年，全球女性劳动力比例已从2022年的39.7%扩大到2023年的约40.1%。资料进一步显示，在日本和美国等国家，女性劳动参与率将从2022年的44.9%和46.3%分别扩大到2023年的45.1%和46.5%。

婴儿奶粉市场驱动因素

  • 世界人口的持续成长预计将推动婴儿奶粉的需求。

预计推动全球婴儿奶粉需求的关键驱动因素之一是世界人口的持续成长。随着这一增长，世界各地出生的婴儿数量也将增加。全球人口的成长和出生人数的增加预计将在预测期内推动全球对婴儿奶粉的需求。

根据世界银行的报告，世界人口将从 2022 年的 79.5 亿增加到 2023 年的 80.2 亿。这代表着世界人口的稳定成长，特别是在印度、马来西亚和越南等开发中国家。印度是世界上人口最多的国家，到 2023 年，该国人口居住约 14.3 亿。人口的不断增长将迅速增加婴儿食品和婴儿奶粉的市场需求。

婴幼儿奶粉市场区隔分析

  • 基于牛奶蛋白的婴儿奶粉预计将推动市场扩张。

消费者日益认识到牛奶蛋白开拓婴儿一般市场提供健康和营养的益处，从而推动了基于牛奶蛋白的婴儿奶粉市场的发展。小儿科广泛推荐以牛奶蛋白为基础的婴儿奶粉作为母乳的替代品。推动这一领域发展的关键因素之一是婴儿奶粉比其他类型的配方奶粉具有多种健康益处。

这种奶粉含有比牛蛋白更多的乳清，更容易消化，适合新生儿。从出生到一岁都可以使用。因此，母亲们不需要改变配方奶粉，从而推动了这一领域的成长。大多数医生都会开立以牛奶为基础的婴儿奶粉，因为这种配方奶粉中的蛋白质与母乳中的蛋白质相似。

此外，不断上升的婴儿死亡率也是该国需要营养奶粉的原因之一。例如，根据美国疾病管制与预防中心的数据，2022年美国新生儿死亡率为每1,000名活产儿5.60例，比2021年每1,000例活产儿5.44例增加3%。预计新生儿死亡率的上升将是在预期期内加强牛奶蛋白婴儿配方奶粉市场的关键因素之一。

主要市场参与企业和新参与企业正在投资于产品发布、市场开拓和合作伙伴关係等关键市场活动，以满足对基于牛奶蛋白的婴儿配方奶粉奶粉日益增长的需求。

预计美国地区将对市场成长做出重大贡献。

美国对有机婴儿配方奶粉的需求预计将会增加。父母对应该购买哪种营养补充剂的认识不断提高，是预测期内有机婴儿配方奶粉需求增长的关键原因之一。此外，全国对婴儿奶粉的需求预计将增加。这些特殊奶粉含有特殊成分，如水解蛋白、胺基酸和益生元。

此外，该公司正在增加对美国婴儿奶粉市场的投资，预计这将推动未来几年的市场成长。例如，2022 年 3 月，美国首批生产有机婴儿奶粉的公司之一 Bobbi 宣布完成 5,000 万美元资金筹措。这也包括由 ParkWest 以及现有投资者 Nextview 和 VMG主导的B 轮资金筹措。这笔资金筹措将使该公司能够加快婴儿奶粉的生产，并支持对营养配方奶粉不断增长的需求。因此，这种增加的投资预计将推动市场成长。

根据美国商务部统计，2023年美国婴幼儿（0-5岁）总数为18,511,160人。其中，男性 9,459,399 人，女性 9,051,761 人。目前，根据世界银行的数据，0 至 14 岁的幼儿占美国人口的 18%。因此，随着婴儿人口的增加，预计未来几年对婴儿奶粉的需求将会成长。

婴儿奶粉主要市场开拓：

  • 2022 年 12 月 - 雅培营养宣布在俄亥俄州鲍灵格林建立新的婴儿配方奶粉生产工厂。该公司计划投资 5 亿美元建造该工厂，并在俄亥俄州西北部地区创造 450 个永久性就业机会。该设施预计将于 2026 年竣工，并于 2027 年开始商业生产。
  • 2022 年 3 月——总部位于纽约、致力于创造新生儿营养新标准的下一代婴儿营养公司 ByHeart 推出了期待已久的奶粉，以更好地为婴儿和父母服务。此配方奶含有有机草饲全脂牛奶和母乳中最丰富的两种蛋白质的独特混合物。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章全球婴儿奶粉市场：依配方奶粉类型

  • 介绍
  • 牛奶蛋白基质
  • 以大豆为基础
  • 蛋白质水解物

第六章 全球婴儿奶粉市场：依形式分类

  • 介绍
  • 粉末
  • 浓缩液
  • 准备使用

第七章 全球婴儿奶粉市场：依通路划分

  • 介绍
  • 离线
  • 在线的

第八章全球婴儿奶粉市场：按地区

  • 介绍
  • 北美洲
    • 依公式类型
    • 按形式
    • 按分销管道
    • 按国家/地区
  • 南美洲
    • 依公式类型
    • 按形式
    • 按分销管道
    • 按国家/地区
  • 欧洲
    • 依公式类型
    • 按形式
    • 按分销管道
    • 按国家/地区
  • 中东/非洲
    • 依公式类型
    • 按形式
    • 按分销管道
    • 按国家/地区
  • 亚太地区
    • 依公式类型
    • 按形式
    • 按分销管道
    • 按国家/地区

第九章竞争环境及分析

  • 主要企业及策略分析
  • 新兴参与企业和巨大的盈利
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第十章 公司简介

  • Abbott
  • Nestle SA
  • Dana Dairy Group
  • Danone
  • Ausnutria Dairy Corporation Ltd.
  • Perrigo Company plc
  • Else Nutrition
  • Biostime
  • HHPL Healthcare
  • Mead Johnson & Company, LLC
  • Estrellas Life Sciences Pvt Ltd
  • Nutricore Biosciences Pvt. Ltd.
  • Morinaga Milk Industry Co.,Ltd.
  • Meiji Holdings Co., Ltd.
  • Bean Stalk Snow Co.,Ltd
简介目录
Product Code: KSI061613040

The global infant formula market is projected to grow at a CAGR of 5.60% over the forecast period, from US$64.183 billion in 2024, and is expected to reach US$84.268 billion by 2029.

Infant formula or baby formula is a process specially designed to provide nutrition and vitamins to infants, especially those under the age of one year. These formulas help babies with reflux issues and additionally offer assistance with newborn children's weight gain. It can also be fed to premature and low-birth-weight babies because it gives them fundamental supplements, minerals, and calories to develop.

The increment in female employment or growing female participation within the worldwide workforce is evaluated to push the market for infant formula forward. The increment in female participation within the workforce is forecasted to boost disposable income and is additionally evaluated to decrease breastfeeding of infants within the worldwide market. Within the past two years, the worldwide female labor force expanded from 39.7% in 2022 to almost 40.1% in 2023, according to the World Bank information. The data further expressed that in countries like Japan and the USA, female workforce participation expanded from 44.9% and 46.3% in 2022 to 45.1% and 46.5%, respectively, in 2023.

GLOBAL INFANT FORMULA MARKET DRIVERS:

  • The constantly growing global population is expected to boost the demand for infant formula.

One of the major driving variables anticipated to push the worldwide demand for infant formula is the continually growing global population. With this increment, the number of children born worldwide will increase. This increment in the worldwide population and increasing childbirth are anticipated to boost the worldwide demand for infant formula in the forecasted period.

The World Bank observed in its report that the global population reached 8.02 billion in 2023, up from 7.95 billion in 2022. This represents a steady rise in the worldwide population, particularly in developing countries such as India, Malaysia, and Vietnam. India is home to the biggest population globally, with around 1.43 billion individuals living within the country in 2023. The expanding population surges the market's requirement for infant food and formula.

GLOBAL INFANT FORMULA MARKET SEGMENT ANALYSIS

  • The cow's milk protein-based infant formula is anticipated to boost the market expansion.

The infant formula market for cow's milk protein-based is driven by expanding consumer mindfulness of the healthy and nutritious benefits of cow milk protein for general infant development. Pediatricians broadly endorse cow milk protein-based infant formulas as an elective to breast milk. One of the primary variables driving this segment's development is the various well-being benefits of cow milk infant formula over other types of infant formula.

This type of formula contains more bovine whey than casein, making it simpler to digest, which makes it more suited to newborns. It is suitable from birth until the child turns one. Therefore, mothers don't need to change the formula driving this segment's growth. Most doctors prescribe cow milk-based infant formula as the protein found in this formula is similar to breast milk proteins.

Moreover, the expanding infant mortality rate is one of the reasons for the need for nutritious infant formula within the nation. For instance, according to the Centers for Disease Control and Prevention, the infant mortality rate within the United States in 2022 was 5.60 per 1,000 live births, which was 3% higher compared to 2021, where the infant mortality rate was 5.44 per 1,000 live births. The increase in cases of newborn mortality is expected to be one of the major reasons for the bolstering of the market for cow milk protein-based infant formula within the anticipated period.

Key market players and new entrants are investing in major market activities such as product launches, developments, and collaborations to meet the growing demand for cow milk protein-based infant formula products.

The United States region is predicted to contribute significantly to market growth.

The demand for organic infant formula is anticipated to rise in the United States. Rising awareness among guardians about the kind of nutrition to purchase is one of the major reasons for the expanding request for organic infant formula within the forecasted period. Moreover, the demand for specialty infant formula is expected to increase nationwide. These specialty formulas have specialized ingredients such as hydrolyzed protein, amino acids, and prebiotics.

Furthermore, companies are increasing their investments in the United States infant formula market, which is expected to drive market growth in the coming years. For instance, in March 2022, Bobbie, one of the first organic infant formula companies manufacturing in the United States, announced that it had closed funding to US$50 million. This included its Series B funding, which was led by Park West, with existing investors Nextview and VMG. This funding will help the company accelerate the production of its infant formula and support the growing demand for nutritious formula. Hence, such rising investments are expected to fuel the market growth.

According to the U.S. Department of Commerce, the total number of infants (0-5 years) in the United States in 2023 was 1,85,11,160. Of this, 94,59,399 were males, and 90,51,761 were females. Currently, according to the World Bank, 18% of the United States population comprises children aged 0-14 years. Hence, in the coming years, with the rising infant population, the demand for infant formula is anticipated to grow.

Global Infant Formula Key Market Developments:

  • December 2022 - Abbott Nutrition unveiled a new formula production facility in Bowling Green, Ohio. The company plans to invest US$500 million in this facility and to create 450 permanent jobs in the northwest Ohio region. The facility construction is expected to be over by 2026, and commercial production is anticipated to start by 2027.
  • March 2022 - ByHeart, a New York-based next-generation baby nutrition company devoted to creating a new standard for newborn nutrition, introduced its much-anticipated cow milk infant formula to better serve babies and parents. The formula contains organic, grass-fed whole milk and a proprietary mix of the two most prevalent proteins in breast milk.

Market Segmentation:

Global Infant Formula Market is segmented and analyzed as below:

By Formula Type

  • Cow's Milk Protein-Based
  • Soy-Based
  • Protein Hydrolysate

By Form

  • Powdered
  • Concentrated Liquid
  • Ready-to-Use

By Distribution Channel

  • Offline
  • Online

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst view

5. GLOBAL INFANT FORMULA MARKET BY FORMULA TYPE

  • 5.1. Introduction
  • 5.2. Cow's Milk Protein-Based
  • 5.3. Soy-Based
  • 5.4. Protein Hydrolysate

6. GLOBAL INFANT FORMULA MARKET BY FORM

  • 6.1. Introduction
  • 6.2. Powdered
  • 6.3. Concentrated Liquid
  • 6.4. Ready-to-Use

7. GLOBAL INFANT FORMULA MARKET BY DISTRIBUTION CHANNEL

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. Online

8. GLOBAL INFANT FORMULA MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Formula Type
    • 8.2.2. By Form
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
      • 8.2.4.1. USA
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Formula Type
    • 8.3.2. By Form
    • 8.3.3. By Distribution Channel
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Formula Type
    • 8.4.2. By Form
    • 8.4.3. By Distribution Channel
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
      • 8.4.4.2. Germany
      • 8.4.4.3. France
      • 8.4.4.4. Spain
      • 8.4.4.5. Italy
      • 8.4.4.6. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Formula Type
    • 8.5.2. By Form
    • 8.5.3. By Distribution Channel
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
      • 8.5.4.2. UAE
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Formula Type
    • 8.6.2. By Form
    • 8.6.3. By Distribution Channel
    • 8.6.4. By Country
      • 8.6.4.1. China
      • 8.6.4.2. Japan
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Taiwan
      • 8.6.4.6. Thailand
      • 8.6.4.7. Indonesia
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Emerging Players and Markey Lucrativeness
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Abbott
  • 10.2. Nestle S.A.
  • 10.3. Dana Dairy Group
  • 10.4. Danone
  • 10.5. Ausnutria Dairy Corporation Ltd.
  • 10.6. Perrigo Company plc
  • 10.7. Else Nutrition
  • 10.8. Biostime
  • 10.9. HHPL Healthcare
  • 10.10. Mead Johnson & Company, LLC
  • 10.11. Estrellas Life Sciences Pvt Ltd
  • 10.12. Nutricore Biosciences Pvt. Ltd.
  • 10.13. Morinaga Milk Industry Co.,Ltd.
  • 10.14. Meiji Holdings Co., Ltd.
  • 10.15. Bean Stalk Snow Co.,Ltd